cSens' Acquisition

cSens was acquired by Biovica on May 17, 2016.

cSens is a diagnostics company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressivenes…

Articles about cSens' Acquisition: